DJIA 17,678.23 -40.31 -0.23%
NASDAQ 4,863.36 -13.16 -0.27%
S&P 500 2,056.15 -4.90 -0.24%
market minute promo

Gilead Sciences (NASDAQ: GILD)

101.08 1.22 (1.22%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GILD $101.08 1.22%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $99.13
Previous Close $99.86
Daily Range $98.59 - $101.82
52-Week Range $63.50 - $116.83
Market Cap $150.5B
P/E Ratio 13.59
Dividend (Yield) $0.00 (0.0%)
Volume 10,918,984
Average Daily Volume 10,234,187
Current FY EPS $9.89

Sector

Healthcare

Industry

Drug Makers

Gilead Sciences (GILD) Description

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide. Website: http://www.gilead.com/

News & Commentary Rss Feed

Bubble Bursting? 3 Top Stock Biotech Stocks to Buy

If biotech stocks fall, long-term investors can consider Celgene Corp., Gilead Sciences Inc., and Biogen Inc. for their portfolios.

Stock Market News for March 26, 2015 - Market News

The Zacks Analyst Blog Highlights: Biogen, Prothena, Vertex, Gilead and Amgen - Press Releases

iShares S&P 100 ETF Experiences Big Outflow

3 Stocks Reiterated As A Buy: SPG, BIIB, GILD

Today's Market: Biotech Correction, Social Media News And Geopolitical Events Moving Stocks

How Gilead And AbbVie Closed The HCV Door On Merck

Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Update - Analyst Blo

Biotech Stock Roundup: Biogen Soars on Alzheimer's Data, Gilead HCV Drugs Label Update - Analyst Blog

Achillion And The Importance Of Hitting The Sweet Spot

Major Biotech Is So-So for Short Sellers

See More GILD News...

GILD's Top Competitors

GILD $101.08 (1.22%)
Current stock: GILD
CELG $117.66 (0.57%)
Current stock: CELG
BIIB $429.09 (-0.59%)
Current stock: BIIB
AMGN $160.55 (-0.04%)
Current stock: AMGN